CHRONIC SPONTANEOUS URTICARIA
Clinical trials for CHRONIC SPONTANEOUS URTICARIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC SPONTANEOUS URTICARIA trials appear
Sign up with your email to follow new studies for CHRONIC SPONTANEOUS URTICARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill for chronic hives tested in everyday clinics
Disease control Not yet recruitingThis study follows 470 adults with chronic spontaneous urticaria (hives) who are starting remibrutinib, a new drug. Researchers will track how well it controls symptoms and any side effects over two years in real-world clinics. The goal is to see if remibrutinib works as well out…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug aims to tame severe allergies by lowering key antibody
Disease control Not yet recruitingThis early-stage study tests a new drug called cizutamig in about 20 adults with IgE-mediated allergies, including food allergies. The main goal is to see if the drug can safely lower IgE levels, which are antibodies that trigger allergic reactions. Researchers will also monitor …
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New shot could tame stubborn hives when pills fail
Disease control Not yet recruitingThis study tests an injection called JYB1904 in 180 adults with chronic spontaneous urticaria (hives and itching lasting over 6 weeks) that isn't well controlled by standard antihistamines. Participants receive either the drug or a placebo every 12 weeks for 48 weeks. The main go…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE3 • Sponsor: Jemincare • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug HRS-3095 aims to soothe stubborn hives
Symptom relief Not yet recruitingThis Phase 2 trial tests whether the experimental drug HRS-3095 can reduce itching and wheals in adults with chronic spontaneous urticaria (hives) that isn't well controlled by antihistamines. About 190 participants will receive either the drug or a placebo daily for 4 weeks. The…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE2 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New shot could tame stubborn hives for good
Symptom relief Not yet recruitingThis study tests a new medicine called MG-K10 for people with chronic hives (itchy welts) that don't get better with standard allergy pills. About 226 teens and adults will receive either the drug or a placebo injection every few weeks. The goal is to see if MG-K10 reduces itchin…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE3 • Sponsor: Shanghai Mabgeek Biotech.Co.Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC